Useful materials
- Access Procedures
- Material Transfer Agreement (Access Procedures)
- Annex A (Access Procedures)
- UK Biobank: Rationale, design and development of a large-scale prospective resource
- Addendum to the main study protocol: category 1
- Addendum to the main study protocol: category 2
- Integrated Pilot Report
- Ethics & Governance Framework
- Participant Information Leaflet
- Further Information Leaflet
- Repeat Assessment Information Leaflet
- Participants’ Invitation Letter
- Consent Form
- Screen notes
- Assessment Form
- Touchscreen Questionnaire
- Touchscreen Questionnaire: Addendum
- Diet Questionnaire
- UK Biobank Report & Financial Statements: 30 September 2012
- ‘No further use’ withdrawal option: February 2008
- Ffurflen Gydsynio/ Welsh language Consent Form
- Taflen Wybodaeth/ Welsh language Information Leaflet
- Report of the UK Biobank HTA licensing number 12002
- Data Showcase User Guide
- VAT note for scientists
- Summary de-identification protocol
- Data management summary
- Data linkage summary
- Why undertake repeat assessments? Regression dilution bias
Further reading
- UK Biobank: Current status & what it means for epidemiology, Health Policy & Technology, August 2012
- What makes UK Biobank special? The Lancet, March 29, 2012
- New Models for Large Prospective Studies, American Journal of Epidemiology
- Biobanking for Epidemiology, Public Health Journal, February 2012
International Journal of Epidemiology